Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Conferences
Guide to authors
Online submissionOnline submission
Permissions
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
naturereprints
About this site
For librarians
 
NPG Resources
Bioentrepreneur
Nature Reviews Drug Discovery
Nature
Nature Medicine
Nature Genetics
Nature Reviews Genetics
Nature Methods
Nature Chemical Biology
news@nature.com
Clinical Pharmacology & Therapeutics
Nature Conferences
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Article
Nature Biotechnology  20, 889 - 894 (2002)
Published online: 12 August 2002; | doi:10.1038/nbt727

Cloned transchromosomic calves producing human immunoglobulin

Yoshimi Kuroiwa1, Poothappillai Kasinathan2, Yoon J. Choi3, Rizwan Naeem4, Kazuma Tomizuka1, Eddie J. Sullivan2, Jason G. Knott2, Anae Duteau3, Richard A. Goldsby3, Barbara A. Osborne5, Isao Ishida1 & James M. Robl2

1  Pharmaceutical Research Laboratory, Kirin Brewery Co., Ltd., 3 Miyahara-cho Takasaki-shi Gunma 370-1295, Japan.

2  Hematech, LLC, 33 Riverside Avenue, Westport, CT 06880.

3  Department of Biology, Amherst College, Amherst, MA 01002.

4  Department of Molecular and Human Genetics, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030.

5  Department of Veterinary and Animal Science, University of Massachusetts, Amherst, MA 01003.

Correspondence should be addressed to Isao Ishida i-ishida@kirin.co.jp or James M. Robl jrobl@hematech.com
Human polyclonal antibodies (hPABs) are useful therapeutics, but because they are available only from human donors, their supply and application is limited. To address this need, we prepared a human artificial chromosome (HAC) vector containing the entire unrearranged sequences of the human immunoglobulin (hIg) heavy-chain (H) and lambda (lambda) light-chain loci. The HAC vector was introduced into bovine primary fetal fibroblasts using a microcell-mediated chromosome transfer (MMCT) approach. Primary selection was carried out, and the cells were used to produce cloned bovine fetuses. Secondary selection was done on the regenerated fetal cell lines, which were then used to produce four healthy transchromosomic (Tc) calves. The HAC was retained at a high rate (78−100% of cells) in calves and the hIg loci underwent rearrangement and expressed diversified transcripts. Human immunoglobulin proteins were detected in the blood of newborn calves. The production of Tc calves is an important step in the development of a system for producing therapeutic hPABs.

MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated

NEWS AND VIEWS
Toward a new cash cow
Nature Biotechnology Research News (01 Sep 2002)

RESEARCH
Manipulation of human minichromosomes to carry greater than megabase-sized chromosome inserts
Nature Biotechnology Research (01 Oct 2000)

 Top
Abstract
Previous | Next
Table of contents
Full textFull text
Download PDFDownload PDF
Send to a friendSend to a friend
Save this linkSave this link
Competing financial interests
Figures & Tables
See also: Research News by Echelard & Meade
Export citation
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Biotechnology
ISSN: 1087-0156
EISSN: 1546-1696
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | Conferences | For authors | Online submission | Permissions | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | naturereprints | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©2002 Nature Publishing Group | Privacy policy